Immunization against GAD induces antibody binding to GAD-independent antigens and brainstem GABAergic neuronal loss
Stiff person syndrome (SPS) is a highly-disabling neurological disorder of the CNS characterized by progressive muscular rigidity and spasms. In approximately 60-80% of patients there are autoantibodies to glutamic acid decarboxylase (GAD), the enzyme that synthesizes gamma-amino butyric acid (GABA)...
Saved in:
Published in | PloS one Vol. 8; no. 9; p. e72921 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Public Library of Science
18.09.2013
Public Library of Science (PLoS) |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Stiff person syndrome (SPS) is a highly-disabling neurological disorder of the CNS characterized by progressive muscular rigidity and spasms. In approximately 60-80% of patients there are autoantibodies to glutamic acid decarboxylase (GAD), the enzyme that synthesizes gamma-amino butyric acid (GABA), the predominant inhibitory neurotransmitter of the CNS. Although GAD is intracellular, it is thought that autoimmunity to GAD65 may play a role in the development of SPS. To test this hypothesis, we immunized mice, that expressed enhanced green fluorescent protein (EGFP) under the GAD65 promoter, with either GAD65 (n = 13) or phosphate buffered saline (PBS) (n = 13). Immunization with GAD65 resulted in autoantibodies that immunoprecipitated GAD, bound to CNS tissue in a highly characteristic pattern, and surprisingly bound not only to GAD intracellularly but also to the surface of cerebellar neurons in culture. Moreover, immunization resulted in immunoglobulin diffusion into the brainstem, and a partial loss of GAD-EGFP expressing cells in the brainstem. Although immunization with GAD65 did not produce any behavioral abnormality in the mice, the induction of neuronal-surface antibodies and the trend towards loss of GABAergic neurons in the brainstem, supports a role for humoral autoimmunity in the pathogenesis of SPS and suggests that the mechanisms may involve spread to antigens expressed on the surface of these neurons. |
---|---|
Bibliography: | Competing Interests: The authors have read the journal's policy and have the following conflicts. Angela Vincent and the University of Oxford holds the following patents “Neurotransmission Disorders” PCT/GB01/02661, June 16th, 2001; ‘Neurological Autoimmune Disorders’ PCT/GB2009/051441, 26 October 2009, and receives royalties and payments for antibody tests but these do not apply to GAD antibodies. The other authors declare that no competing interests exist. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. Conceived and designed the experiments: TC AV. Performed the experiments: TC PP HA MM RD. Analyzed the data: TC PP HA RD CJB AV. Contributed reagents/materials/analysis tools: FE GS. Wrote the paper: TC HA AV. |
ISSN: | 1932-6203 1932-6203 |
DOI: | 10.1371/journal.pone.0072921 |